Real-world overall survival comparison between first-line Bruton tyrosine kinase inhibitors in treating chronic lymphocytic leukemia/small lymphocytic lymphoma: An analysis of Veterans Health Administration data. [PDF]
J Manag Care Spec PharmFitzgerald L +13 more
europepmc +1 more source
Update on Oral Oncolytics: A Focus on Hematology Drugs [PDF]
, 2020 Tadros, Monica
core +1 more source
Zanubrutinib Combined With Rituximab in the Treatment of Bing-Neel Syndrome: A Case Report. [PDF]
Clin Case RepZhang R, Chang J, Shen Y, Hu P, Zhang L.
europepmc +1 more source
A pharmacovigilance study of Bruton's tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase. [PDF]
Front ImmunolQu H +7 more
europepmc +1 more source
Solitary Hepatic Plasmacytoma With IgM Monoclonal Gammopathy: A Case Report. [PDF]
Case Rep HematolPoppe B, Farooqui A, Lin Y.
europepmc +1 more source
BTK Inhibition in Hematology: From CLL/SLL to Emerging Applications Across B-Cell and Immune Disorders. [PDF]
BiomoleculesDuminuco A +9 more
europepmc +1 more source
Establishment and Validation of a UPLC-MS/MS Method for Quantitative Determination of Zanubrutinib and Posaconazole in Rat Plasma: Application in Drug-Drug Interaction Studies. [PDF]
Drug Des Devel TherXia H, Shen Y, Xu X, Wu J, Lin G, Du X.
europepmc +1 more source
Bruton tyrosine kinase inhibitors and invasive aspergillosis and mucormycosis: a case report and multi-center exploratory retrospective study. [PDF]
ASM Case RepBhaimia E, Russell D, Santos CAQ.
europepmc +1 more source
Zanubrutinib‑Induced Symmetrical Soft Tissue Forearm Swelling in a Patient With Waldenström Macroglobulinemia. [PDF]
CureusSamperio VM, Ghonge A, Dasanu CA.
europepmc +1 more source